MedTrace Logo

Study of Chemoradiotherapy With Envafolimab For The Treatment of Locally Advanced Cervical Cancer

NCT05799469 · Status: NOT_YET_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2023-04-05

No results posted yet for this study

Summary

This is a single-arm, single-center, exploratory study, the purpose of this study is to evaluate the efficacy and safety of envafolimab combined with Chemoradiotherapy in participants with locally advanced cervical cancer.

Conditions

  • Locally Advanced Cervical Cancer

Interventions

DRUG

Envafolimab

SC

DRUG

Cisplatin

IV infusion

RADIATION

External Beam Radiotherapy (EBRT)

45-50.4Gy

RADIATION

Brachytherapy (BT)

Performed according to clinically required dose

Sponsors & Collaborators

  • Chongqing University Cancer Hospital

    lead OTHER

Principal Investigators

  • Qi Zhou, PhD · Chongqing University Cancer Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2027-05-31
Completion
2027-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05799469 on ClinicalTrials.gov